Home Home Home Inbox Home Search

Event

Molecular Evidences for Antifibrotic Potentials of Nintedanib in Interstitial Lung Disease Associated with Systemic Sclerosis [Board No. 907]

Location: Board no. 907
Session Type: RAPiD: Rapid Abstract Poster Discussion Session
Tuesday
May
22
9:15 AM
11:15 AM

Speaker(s)/Author(s)

Ilia Atanelishvili

MSc
medical university of south carolina

Tanjina Akter

MSc
Medical University of South Carolina

Lutz Wollin

PhD
Boehringer Ingelheim Pharma GmbH & Co. KG

Atsushi Noguchi

MD
Hokkaido University Graduate School of Medicine

Galina S. Bogatkevich

MD, PhD;
medical university of south carolina

Richard M. Silver

MD
Medical University of South Carolina;MUSC

View Abstract

Molecular Evidences for Antifibrotic Potentials of Nintedanib in Interstitial Lung Disease Associated with Systemic Sclerosis

Parent Sessions

  • C28 - ROLE OF CELLULAR CROSS TALK IN LUNG HOMEOSTASIS AND AGING...
    05-22-2018 9:15 AM - 11:15 AM
    • Home Home Home Inbox Home Search